Over $5 Million Bet On Exicure? Check Out These 4 Penny Stocks Insiders Are Buying

Wall Street closed lower for the fourth straight session on Monday. Investors, meanwhile, focused on some notable insider trades.

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

United Insurance Holdings

• The Trade: United Insurance Holdings Corp. UIHC Chief Operating Officer Christopher Griffith bought a total of 20,000 shares at an average price of $0.57. To acquire these shares, it cost around $11.34 thousand.
• What’s Happening: United Insurance, last month, posted a Q3 loss of $1.34 per share.
• What United Insurance Does: United Insurance Holdings Corp is a holding company primarily engaged in the residential and commercial property and casualty insurance business in the United States.

Exicure

• The Trade: Exicure, Inc. XCUR 10% owner CBI USA, Inc. acquired a total of 3,400,000 shares at an average price of $1.60. The insider spent around $5.44 million to buy those shares.
• What’s Happening: Exicure announced the termination of its collaboration agreements with AbbVie and Ipsen BioPharm.
• What Exicure Does: Exicure Inc is a clinical-stage biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss.

Check this out: CNN Fear & Greed Index Moves To 'Fear' Zone Amid Recession Concerns

Don’t forget to check out our premarket coverage here

Stryve Foods

• The Trade: Stryve Foods, Inc. SNAX Director Gregory S. Christenson acquired a total of 25,100 shares at an average price of $0.72. To acquire these shares, it cost around $18.07 thousand.
• What’s Happening: Stryve Foods, last month, reported worse-than-expected Q3 sales results.
• What Stryve Foods Does: Stryve Foods Inc is focused on manufacturing and marketing highly differentiated healthy snacks that disrupt traditional snacking categories. It offers convenient snacks that are lower in sugar and carbohydrates and higher in protein than other snacks.

Cingulate

• The Trade: Cingulate Inc. CING CEO Shane J Schaffer acquired a total of 10,000 shares at an average price of $1.02. The insider spent $10.17 thousand to buy those shares.
• What’s Happening: Cingulate, last month, reported quarterly losses of $0.36 per share.
• What Cingulate Does: Cingulate Inc is a clinical stage biopharmaceutical company utilizing its proprietary precision timed release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes.

Also check this out: CNN Fear & Greed Index Moves To 'Fear' Zone Amid Recession Concerns